CNA earnings analysis
What we found in CNA's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
CNA delivered Q2 operating-revenue growth of $71 million to $3.834 billion and reported net income of $321 million, up $22 million year over year, with EPS of $1.18. However, core income declined $11 million to $324 million as P&C underwriting gain fell from $150 million to $92 million; higher $701 million investment income partially mitigated weaker underlying loss ratios. Premium momentum remained favorable in Specialty and Commercial, while International written premiums declined and all three P&C segments experienced combined-ratio deterioration. Cash generation stayed substantial at $1.042 billion for the first half, though it declined $158 million year over year; the filing provides no numeric earnings or revenue guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue and reported earnings increased
- Q2 total operating revenues rose $71 million, or 1.9%, year over year to $3.834 billion, and increased $154 million, or 4.2%, from Q1 2026 revenue of $3.680 billion. Net income increased $22 million to $321 million, while diluted EPS was $1.18 versus $1.10 in Q2 2025.
- Investment income offset underwriting pressure
- Net investment income increased $39 million year over year to $701 million, driven by higher limited-partnership/common-stock returns and higher fixed-income income. The fixed-income portfolio's effective income yield held at 4.9%.
- Commercial premium growth remained solid
- Commercial net written premiums increased $80 million to $1.643 billion, supported by favorable renewal premium change and higher new business; new business rose $26 million to $446 million. Segment core income nevertheless rose $14 million to $232 million due to investment income.
- Specialty growth driven by new business and rate
- Specialty net written premiums rose $45 million to $937 million, with new business increasing $53 million to $175 million and renewal rate improving to 4% from 3%.
- Operating cash flow funded shareholder returns
- Six-month operating cash flow was $1.042 billion, despite declining $158 million from $1.200 billion a year earlier; the company returned $848 million through $812 million of dividends and $36 million of buybacks.
- Revolver remains fully undrawn
- Liquidity remained available: there were no borrowings under the $250 million senior unsecured revolving credit facility and no FHLBC borrowings outstanding at June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Underlying underwriting profitability weakened
- P&C underwriting gain fell $58 million year over year to $92 million, and underlying underwriting gain declined $60 million to $153 million. Specialty's combined ratio worsened 2.9 points to 96.5%, Commercial's rose 1.7 points to 96.5%, and International's increased 4.1 points to 96.9%.
- Reserve-development and legacy mass-tort exposure
- The company recorded $91 million of unfavorable prior-year loss reserve development in Q2 2026. Corporate & Other included a $77 million after-tax charge, largely associated with legacy mass-tort abuse reserves.
- Casualty severity and expense headwinds
- Commercial's Q2 loss ratio increased 2.4 points to 69.5%, primarily from excess casualty and workers' compensation; International's expense ratio rose 2.0 points to 34.9% amid talent and technology investments and higher acquisition costs.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.18
- Segment
- Specialty: net written premiums $937 million, up from $892 million; net earned premiums $878 million, up from $862 million.
- Segment
- Commercial: net written premiums $1.643 billion, up from $1.563 billion; net earned premiums $1.441 billion, up from $1.402 billion.
- Segment
- International: net written premiums $385 million, down from $391 million; net earned premiums $337 million, up from $324 million.
- Segment
- Life & Group: net earned premiums $103 million, down from $106 million.
What they said about what is next.
The 10-Q contains no quantitative earnings or revenue outlook. Management states that present cash flows are sufficient for current and expected working-capital and debt-obligation needs and that it does not expect this to change in the near term.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 4, 2026
- CNA Financial Corporation reported Q1 2026 earnings with revenue of $666 million and an EPS of $1.37, both exceeding expectations. The company raised its full-year EPS guidance to a range of $5.30 to $5.50 due to strong…
- 10-K · February 10, 2026
- CNA's 2025 results show revenue and earnings expansion with total revenues of $14,989 million (2025 vs. $14,270 million in 2024) and diluted EPS of $4.69 (2025 vs. $3.52 in 2024). Operating cash flow remained strong at…
- 10-Q · November 3, 2025
- CNA reported higher top-line and materially improved underwriting and investment results in Q3 2025: total operating revenues were $3,824 million (Q3 2025) vs. $3,628 million (Q3 2024), and core income rose to $409…
- 10-Q · August 4, 2025
- CNA Financial reported strong Q2 2025 results, with revenue reaching $3.72 billion, up 5.7% year-over-year, driven primarily by commercial insurance growth. EPS exceeded expectations at $1.23, a notable increase from…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CNA makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever